<code id='1A19EB5089'></code><style id='1A19EB5089'></style>
    • <acronym id='1A19EB5089'></acronym>
      <center id='1A19EB5089'><center id='1A19EB5089'><tfoot id='1A19EB5089'></tfoot></center><abbr id='1A19EB5089'><dir id='1A19EB5089'><tfoot id='1A19EB5089'></tfoot><noframes id='1A19EB5089'>

    • <optgroup id='1A19EB5089'><strike id='1A19EB5089'><sup id='1A19EB5089'></sup></strike><code id='1A19EB5089'></code></optgroup>
        1. <b id='1A19EB5089'><label id='1A19EB5089'><select id='1A19EB5089'><dt id='1A19EB5089'><span id='1A19EB5089'></span></dt></select></label></b><u id='1A19EB5089'></u>
          <i id='1A19EB5089'><strike id='1A19EB5089'><tt id='1A19EB5089'><pre id='1A19EB5089'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:28122
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          HCA sued by state AG for quality issues at Mission Health
          HCA sued by state AG for quality issues at Mission Health

          MissionhealthsysteminNorthCarolina.MikeBellemeforSTATNorthCarolina’sattorneygeneralissuingHCAHealthc

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          What it’s like to watch children die of measles

          AtoddlerreceivingameaslesvaccinationintheDemocraticRepublicoftheCongo.UNIORKANNAH/AFPviaGettyImagesO